Stimulation of Macrophages with the β-glucan Produced by Aureobasidium Pullulans Promotes the Secretion of Tumor Necrosis Factor-related Apoptosis Inducing Ligand (TRAIL)
Overview
Authors
Affiliations
A β-glucan produced by Aureobasidium pullulans (AP-PG) is consisting of a β-(1,3)-linked main chain with β-(1,6)-linked glucose side residues. Various β-glucans consisting of β-(1,3)-linked main chain including AP-PG are believed to exhibit anti-tumor activities, and actually, anti-tumor activities of AP-PG in mice have been demonstrated. In this study, we demonstrate that stimulation with AP-PG induces TRAIL expression in mouse and human macrophage-like cell lines. TRAIL is known to be a cytokine which specifically induces apoptosis in transformed cells, but not in untransformed cells. The expression of TRAIL mRNA after stimulation with AP-PG was increased in RAW264.7 cells, Mono Mac 6 cells, and macrophage-differentiated THP-1 cells. The mRNA expression of TNF-α and FasL is only weakly increased after stimulation with AP-PG. The induction activity of TRAIL by curdlan, a bacterial β-glucan, was very similar to that by AP-PG in RAW264.7 cells, but weaker in macrophage-differentiated THP-1 cells. Activation of caspases was found in HeLa cells after treatment with the supernatant of cultured medium from AP-PG-stimulated Mono Mac 6 cells, and was inhibited by the anti-TRAIL neutralizing antibody. These findings suggest that the stimulation with AP-PG effectively induces TRAIL in macrophages, and that it may be related to apoptosis induction of tumor cells.
Guo F, Liu H, Li X, Hu Z, Huang J, Bi R Antioxidants (Basel). 2024; 13(1).
PMID: 38247473 PMC: 10812733. DOI: 10.3390/antiox13010048.
Kiss A, Hariri Akbari F, Marchev A, Papp V, Mirmazloum I Life (Basel). 2023; 13(8).
PMID: 37629481 PMC: 10455657. DOI: 10.3390/life13081623.
Kim J, Seo J, No H, Kuge T, Mori T, Kimoto H Biomedicines. 2023; 11(2).
PMID: 36831065 PMC: 9953391. DOI: 10.3390/biomedicines11020529.
Kwon N, Vinayagam R, Do G, Lee K, Kang S Appl Biochem Biotechnol. 2022; 195(5):3027-3046.
PMID: 36495375 DOI: 10.1007/s12010-022-04241-8.
Hu X, Shui Y, Hirano H, Kusano K, Guo W, Fujino M Cancer Immunol Immunother. 2022; 72(3):719-731.
PMID: 36053290 PMC: 10992518. DOI: 10.1007/s00262-022-03276-4.